Neo-adjuvant chemo-(immuno-)therapy of advanced squamous-cell head and neck carcinoma: a multicenter, phase III, randomized study comparing cisplatin + 5-fluorouracil (5-FU) with cisplatin + 5-FU + recombinant interleukin 2. [electronic resource]
Producer: 19981203Description: 149-56 p. digitalISSN:- 0340-7004
- Adult
- Aged
- Antineoplastic Agents -- adverse effects
- Carcinoma, Squamous Cell -- drug therapy
- Cisplatin -- adverse effects
- Drug Therapy, Combination
- Female
- Fluorouracil -- adverse effects
- Head and Neck Neoplasms -- drug therapy
- Humans
- Interleukin-2 -- adverse effects
- Male
- Middle Aged
- Recombinant Proteins -- adverse effects
No physical items for this record
Publication Type: Clinical Trial; Clinical Trial, Phase III; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.